Bioprocess Optimization and Digital Bio-manufacturing: Global Markets, 2018-2023 - ResearchAndMarkets.com
The "Bioprocess Optimization and Digital Bio-manufacturing: Global Markets" report has been added to ResearchAndMarkets.com's offering.
Over the last few years, the biopharmaceuticals market has witnessed tremendous growth. Innovation in the types of biological drug candidates has been remarkable.
The expiration of patents of many blockbuster drugs has led to the rise of the biosimilars market, too. As a result, the biologic drug manufacturers who had been practicing age-old business models and traditional methods of biomanufacturing are now faced with numerous challenges. Improvement is required in process productivity in the form of production processes becoming faster and more cost-effective, and the processes also need to be GMP (good manufacturing practices)-compliant.
The U.S. Food and Drug Administration (FDA) launched the Process Analytical Technology (PAT) initiative in 2004 with an aim to imbibe quality in production processes by way of monitoring and controlling the processes in real-time. Sophisticated techniques of analysis, single-use technologies, and continuous processing are becoming popular as methods that can bring about efficiencies in the biomanufacturing processes, as well as save time and investments.
The biopharmaceutical market is rapidly adopting the smart technologies that define the industrial revolution 4.0 (or Industry 4.0). The highly regulated nature of the biopharmaceutical industry, complemented by the complexity of biological production processes has delayed the entry of Industry 4.0 in this sector.
There is heightened activity in the mergers and acquisitions among technology-driven companies, particularly single-use technologies and information technology companies.
Another factor driving the bioprocess optimization and digital biomanufacturing market is the significant growth seen in contract manufacturing organizations, specifically in emerging countries.
Key Topics CoveredChapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Chapter 4 Market Breakdown by Technology Type
Chapter 5 Market Breakdown by Application
Chapter 6 Market Breakdown by Region
Chapter 7 Industry Structure
Chapter 8 Patent Review/ New Developments
Chapter 9 New Developments/ Regulatory Aspects
Chapter 10 Critical Issues in Adopting Digital Biomanufacturing
Chapter 11 Emerging Trends in Digital Biomanufacturing
Chapter 12 Analysis of Market Opportunities
Chapter 13 Company Profiles
- 3M Co.
- ABB Group
- AB Sciex LLC
- Agilent Technologies Inc.
- Alva Laval AB
- Applied Materials Inc.
- Applikon Biotechnology B.V.
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- Emerson Electric Co.
- Eppendorf AG
- Endress+Hauser AG
- GEA Group
- GE Healthcare Life Sciences
- Hitachi High-Technologies Corp.
- Microsoft Corp.
- Novasep Inc.
- Oracle International Corp.
- Pall Corp.
- Parker Hannifin Corp.
- Perkinelmer Inc.
- Phenomenex Inc.
- PSC Biotech Corp.
- Purolite Corp.
- Repligen Corp.
- Rockwell Automation Inc.
- Thermo Fisher Scientific Inc.
- Tosoh Bioscience LLC
- Waters Corp.
- Werum It Solutions Gmbh
- Yokagawa Electric Corp.
For more information about this report visit https://www.researchandmarkets.com/research/2jvcpl/bioprocess?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20181211005486/en/